Global Anti-Obesity Drugs Market 2017-2023: Market is Estimated to Witness a CAGR of 20.9% - Key Players are F. Hoffmann La Roche, GSK, Orexigen Therapeutics, Vivus Therapeutics, and Eisai

DUBLIN, Feb. 1, 2018 /PRNewswire/ -- The "Global Anti-Obesity Drugs Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to ResearchAndMarkets.com's offering. The Global Anti-Obesity Drugs Market is estimated to witness a CAGR of 20.9% during...

from PR Newswire: //http://ift.tt/2GDhtZI